Maladie d'Alzheimer  Alzheimer's disease index  Dernières nouvelles
Associations de familles Neurological disorders Protéines tau / Tau proteins
Dégénérescence frontotemporale Immunological tools/Outils  Communication / Enseignement
Autres pathologies VCDN group Equipe VCDN

anti-Tau_Ser199P

CODE 990
This polyclonal antibody is raised against phosphorylated Serine 419 (according to the numbering of the longest human tau isoform [1]). The antigen is described in references 2 and 3, and also the immunochemical characterization.

Source:

A New Zealand rabbit was immunized sub-cutaneously with a KLH coupled peptide (Neosystems, France).

Applications:

This antibody can be used for immunohistochemistry and western blotting.

Specificity:

1. Western-blot : in homogenates from brain of AD patients, this antibody mostly recognizes normal and pathological tau proteins that are phosphorylated on serine 199.

2. Immunohistochemistry : this antibody recognizes the early changes of neurofibrillary degeneration (tangles and dystrophic neurites, neuritic plaques) on frozen sections of Alzheimer's disease cortical brain tissue. Excellent also on paraffin sections.

Excellent for transgenic mice that develop a tau pathology

Presentation:

This rabbit polyclonal antibody to human Tau proteins is in 50% glycerol. There is no other additive or preservative. It is a total serum.

Instructions for use:

1. For Western-blot, a final dilution of 1/10000 in TBS-Tween buffer + 5% non-fat dry milk is useful to detect Tau proteins in cortical brain homogenates.

2. For immunohistochemistry, a final dilution of 1/1000 (in Coons buffer) is suggested for immunostaining on frozen sections of cortical brain tissue.

Note: The recommended concentrations are approximative values. For each application, a dose response assay should be performed to determine the optimal concentration for use.

FOR RESEARCH USE ONLY

___________________________________________

References :

[1] Goedert M. and Jakes R., EMBO J. (1990); 9, 4225-4230

[2] Sergeant N, David JP, Lefranc D, Vermersch P, Wattez A, Delacourte A.Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases.FEBS Lett. 1997 Aug 4;412(3):578-82. PMID: 9276470; UI: 97420485

[3] Sergeant N, Wattez A, Delacourte A. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms. J Neurochem. 1999 Mar;72(3):1243-9. PMID: 10037497; UI: 99155101

See also the results on tau transgenic mice (Gotz et al).
 
Maladie d'Alzheimer  Alzheimer's disease index  Dernières nouvelles
Associations de familles Neurological disorders Protéines tau / Tau proteins
Dégénérescence frontotemporale Immunological tools/Outils  Communication / Enseignement
Autres pathologies VCDN group Equipe VCDN